Insider transactions

EDGAR

PHARMACYTE BIOTECH, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
6 transactions, 160,000 shares
Sum of shares × price per share: 128,708
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–24 of 24

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-03-31 Filed 2026-07-17WEINSTEIN ROBERT Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock
Acquired (A)0——0Direct (D) No
F1
  • F1 The reported grant was made in error and has been cancelled.
Open filing 0001683168-26-005619 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-07-17Abecassis Michael M Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock
Acquired (A)0——0Direct (D) No
F1
  • F1 The reported grant was made in error and has been cancelled.
Open filing 0001683168-26-005621 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-07-17WALKER WAYNE REMELL Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock
Acquired (A)0——0Direct (D) No
F1
  • F1 The reported grant was made in error and has been cancelled.
Open filing 0001683168-26-005622 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-07-17SCHECHTER JONATHAN Director
J

Other acquisition or disposition (describe transaction)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock
Acquired (A)0——0Direct (D) No
F1
  • F1 The reported grant was made in error and has been cancelled.
Open filing 0001683168-26-005620 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-02SCHECHTER JONATHAN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (119,170) — exercise price 0.67
Acquired (A)119,1700—119,170Direct (D) No
F1
  • F1 The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Schechter.
Open filing 0001683168-26-002631 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-02WALKER WAYNE REMELL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (119,170) — exercise price 0.67
Acquired (A)119,1700—119,170Direct (D) No
F1
  • F1 The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker.
Open filing 0001683168-26-002632 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-02Abecassis Michael M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (119,170) — exercise price 0.67
Acquired (A)119,1700—119,170Direct (D) No
F1
  • F1 The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis.
Open filing 0001683168-26-002630 Read from the filing’s XML Dispute this row
2026-03-31 Filed 2026-04-02WEINSTEIN ROBERT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (119,170) — exercise price 0.67
Acquired (A)119,1700—119,170Direct (D) No
F1
  • F1 The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein.
Open filing 0001683168-26-002633 Read from the filing’s XML Dispute this row
2026-01-07 Filed 2026-01-07SCHECHTER JONATHAN Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0000.8436
16,872

Derived: shares × price per share. Exact value 16872.0000.

192,500Direct (D) No— Open filing 0001683168-26-000147 Read from the filing’s XML Dispute this row
2026-01-07 Filed 2026-01-07Silverman Joshua Director · Officer: CEO and President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)40,0000.8329
33,316

Derived: shares × price per share. Exact value 33316.0000.

416,250Direct (D) No— Open filing 0001683168-26-000148 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-07SCHECHTER JONATHAN Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0000.7904
15,808

Derived: shares × price per share. Exact value 15808.0000.

172,500Direct (D) No— Open filing 0001683168-26-000147 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-07Silverman Joshua Director · Officer: CEO and President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)30,0000.7889
23,667

Derived: shares × price per share. Exact value 23667.0000.

376,250Direct (D) No— Open filing 0001683168-26-000148 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-07SCHECHTER JONATHAN Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)20,0000.7776
15,552

Derived: shares × price per share. Exact value 15552.0000.

152,500Direct (D) No— Open filing 0001683168-26-000147 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-07Silverman Joshua Director · Officer: CEO and President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)30,0000.7831
23,493

Derived: shares × price per share. Exact value 23493.0000.

346,250Direct (D) No— Open filing 0001683168-26-000148 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12WALKER WAYNE REMELL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)37,5000—37,500Direct (D) No— Open filing 0001683168-25-009115 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12WALKER WAYNE REMELL Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)16,8751.02
17,212.5

Derived: shares × price per share. Exact value 17212.50.

20,625Direct (D) No
F1
  • F1 Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
Open filing 0001683168-25-009115 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12SCHECHTER JONATHAN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)150,0000—200,000Direct (D) No— Open filing 0001683168-25-009113 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12SCHECHTER JONATHAN Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)67,5001.02
68,850

Derived: shares × price per share. Exact value 68850.00.

132,500Direct (D) No
F1
  • F1 Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
Open filing 0001683168-25-009113 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12Abecassis Michael M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)37,5000—39,167Direct (D) No— Open filing 0001683168-25-009112 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12Abecassis Michael M Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)16,8751.02
17,212.5

Derived: shares × price per share. Exact value 17212.50.

22,292Direct (D) No
F1
  • F1 Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
Open filing 0001683168-25-009112 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12Silverman Joshua Director · Officer: CEO and President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)575,0000—575,000Direct (D) No— Open filing 0001683168-25-009114 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12Silverman Joshua Director · Officer: CEO and President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)258,7501.02
263,925

Derived: shares × price per share. Exact value 263925.00.

316,250Direct (D) No
F1
  • F1 Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
Open filing 0001683168-25-009114 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12WEINSTEIN ROBERT Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)75,0000—75,000Direct (D) No— Open filing 0001683168-25-009116 Read from the filing’s XML Dispute this row
2025-12-12 Filed 2025-12-12WEINSTEIN ROBERT Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)33,7501.02
34,425

Derived: shares × price per share. Exact value 34425.00.

41,250Direct (D) No
F1
  • F1 Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
Open filing 0001683168-25-009116 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–27 of 27

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
CITADEL ADVISORS LLC Partly reported under another manager140,414 SH57,654 dollarsLower by 142,967 Prior quarter: 283,381Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager123,934 SH50,892 dollarsLower by 313 Prior quarter: 124,247Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager64,738 SH26,581 dollarsHigher by 26,751 Prior quarter: 37,987Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager64,153 SH26,341 dollarsHigher by 34,089 Prior quarter: 30,064Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 56,778 SH23,336 dollarsUnchanged Prior quarter: 56,778Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager32,624 SH13,395 dollarsUnchanged Prior quarter: 32,624Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
XTX Topco Ltd Partly reported under another manager30,386 SH12,476 dollarsLower by 3,794 Prior quarter: 34,180Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager30,063 SH12,344 dollarsLower by 14,790 Prior quarter: 44,853Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
StoneX Group Inc. Partly reported under another manager30,006 SH12,321 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
Schonfeld Strategic Advisors LLC 26,247 SH10,777 dollarsLower by 679 Prior quarter: 26,926Open filing 0001665241-26-000003 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 23,452 SH9,639 dollarsUnchanged Prior quarter: 23,452Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
EQUITEC PROPRIETARY MARKETS, LLC 22,227 SH9,126 dollarsUnchanged Prior quarter: 22,227Open filing 0001420506-26-002484 Filed 2026-11-04 Dispute this row
Ground Swell Capital, LLC 19,612 SH8,053 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002533 Filed 2026-11-09 Dispute this row
COMMONWEALTH EQUITY SERVICES, LLC Partly reported under another manager10,255 SH4,210 dollarsLower by 10,000 Prior quarter: 20,255Open filing 0000312272-26-000024 Filed 2026-11-02 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager4,873 SH2,001 dollarsLower by 15 Prior quarter: 4,888Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
Allworth Financial LP 714 SH294 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager303 SH126 dollarsUnchanged Prior quarter: 303Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
Covestor Ltd 275 SH0 dollarsUnchanged Prior quarter: 275Open filing 0001909846-26-000012 Filed 2026-10-30 Dispute this row
Keating Financial Advisory Services, Inc. 134 SH55 dollarsNot in the prior quarter’s filings read Open filing 0002103443-26-000004 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager30 SH12 dollarsLower by 4,112 Prior quarter: 4,142Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
BFSG, LLC 5 SH3 dollarsUnchanged Prior quarter: 5Open filing 0001706836-26-000005 Filed 2026-10-30 Dispute this row
CoreCap Advisors, LLC 4 SH2 dollarsUnchanged Prior quarter: 4Open filing 0001902501-26-000006 Filed 2026-10-08 Dispute this row
BARCLAYS PLC Partly reported under another manager4 SH2 dollarsLower by 188 Prior quarter: 192Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
CALDWELL SUTTER CAPITAL, INC. 2 SH1 dollarsUnchanged Prior quarter: 2Open filing 0000702007-26-000013 Filed 2026-11-09 Dispute this row
FINANCIAL CONSULATE, INC 2 SH1 dollarsUnchanged Prior quarter: 2Open filing 0001624510-26-000007 Filed 2026-10-23 Dispute this row
NewEdge Advisors, LLC 2 SH1 dollarsUnchanged Prior quarter: 2Open filing 0001213900-26-119695 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager1 SH0 dollarsUnchanged Prior quarter: 1Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 86,100 SH
  • HRT FINANCIAL LP 15,451 SH
  • SIMPLEX TRADING, LLC 12,400 SH
  • GROUP ONE TRADING LLC 500 SH
  • Sachetta, LLC 14 SH
  • SBI Securities Co., Ltd. 6 SH
  • HARBOUR INVESTMENTS, INC. 3 SH
  • MORGAN STANLEY 2 SH
  • HUNTINGTON NATIONAL BANK 1 SH
  • Johnson Financial Group, Inc. 1 SH
  • MCF Advisors LLC 1 SH
  • BFC Planning, Inc. 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Mitchell P. Kopin Common Stock, $0.0001 par value per share4.99532,254.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 7Open filing 0001213900-26-016526 Dispute this row
Daniel B. Asher Common Stock, $0.0001 par value per share4.99531,086.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 7Open filing 0001213900-26-016526 Dispute this row
Intracoastal Capital LLC Common Stock, $0.0001 par value per share4.99532,254.0012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 7Open filing 0001213900-26-016526 Dispute this row
Mitchell P. Kopin Common Stock, $0.0001 par value per share9.99695,715.0009/30/2025 Filed 2025-11-07SCHEDULE 13G/AAmendment 6Open filing 0001213900-25-107726 Dispute this row
Daniel B. Asher Common Stock, $0.0001 par value per share9.99686,533.0009/30/2025 Filed 2025-11-07SCHEDULE 13G/AAmendment 6Open filing 0001213900-25-107726 Dispute this row
Intracoastal Capital LLC Common Stock, $0.0001 par value per share9.99695,715.0009/30/2025 Filed 2025-11-07SCHEDULE 13G/AAmendment 6Open filing 0001213900-25-107726 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,708,462 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015124,844
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to PHARMACYTE BIOTECH, INC.